Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Radiation Biology, Vol. 77, Iss. 2, 2001-02 ,pp. : 195-204

Informa Healthcare

Access to resources Recommend Favorite

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

By Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 306-316

Informa Healthcare

Access to resources Recommend Favorite

Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours

By Liu Johnson   Ching Lai-Ming   Goldthorpe Michael   Sutherland Rachel   Baguley Bruce   Kirker James   McKeage Mark  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 661-669

Springer Publishing Company

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite

Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor

By Pang J.-H.   Cao Z.   Joseph W.R.   Baguley B.C.   Ching L.-M.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1282-1289

Elsevier

Access to resources Recommend Favorite